Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10189)
All Articles published online
|
Publishing Process of This Article
|
Jul 14, 2016 (publication date) through Jan 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Szűcs D, Béres NJ, Rokonay R, Boros K, Borka K, Kiss Z, Arató A, Szabó AJ, Vannay &, Sziksz E, Bereczki C, Veres G. Increased duodenal expression of miR-146a and -155 in pediatric Crohn’s disease. World J Gastroenterol 2016; 22(26): 6027-6035 [PMID: 27468194 DOI: 10.3748/wjg.v22.i26.6027] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5330/full/v22/i26/6027.htm |
| Number | Citing Articles |
| 1 |
Viola Neudecker, Xiaoyi Yuan, Jessica L. Bowser, Holger K. Eltzschig. MicroRNAs in mucosal inflammation. Journal of Molecular Medicine 2017; 95(9): 935 doi: 10.1007/s00109-017-1568-7
|
| 2 |
Karla A. Bascuñán, Francisco Pérez-Bravo, Gabriella Gaudioso, Valentina Vaira, Leda Roncoroni, Luca Elli, Erika Monguzzi, Magdalena Araya. A miRNA-Based Blood and Mucosal Approach for Detecting and Monitoring Celiac Disease. Digestive Diseases and Sciences 2020; 65(7): 1982 doi: 10.1007/s10620-019-05966-z
|
| 3 |
Mohammad Mirzakhani, Ali Khalili, Mehdi Shahbazi, Saeid Abediankenari, Soheil Ebrahimpour, Mousa Mohammadnia-Afrouzi. Under-expression of microRNA-146a and 21 and their association with Crohn’s disease. Indian Journal of Gastroenterology 2020; 39(4): 405 doi: 10.1007/s12664-020-01059-2
|
| 4 |
Seyed Shahabeddin Mortazavi-Jahromi, Mona Aslani, Abbas Mirshafiey. A comprehensive review on miR-146a molecular mechanisms in a wide spectrum of immune and non-immune inflammatory diseases. Immunology Letters 2020; 227: 8 doi: 10.1016/j.imlet.2020.07.008
|
| 5 |
Soudeh Ghafouri-Fard, Reyhane Eghtedarian, Mohammad Taheri. The crucial role of non-coding RNAs in the pathophysiology of inflammatory bowel disease. Biomedicine & Pharmacotherapy 2020; 129: 110507 doi: 10.1016/j.biopha.2020.110507
|
| 6 |
Xiangjun Xiao, Xiangbing Mao, Daiwen Chen, Bing Yu, Jun He, Hui Yan, Jianping Wang. miRNAs Can Affect Intestinal Epithelial Barrier in Inflammatory Bowel Disease. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.868229
|
| 7 |
Rasha Ahmed Ghorab, Shaimaa H. Fouad, Ahmed F. Sherief, Eman M. El-Sehsah, Sara Shamloul, Sara I. Taha. MiR-146a (rs2910164) Gene Polymorphism and Its Impact on Circulating MiR-146a Levels in Patients with Inflammatory Bowel Diseases. Inflammation 2024; doi: 10.1007/s10753-024-02108-0
|
| 8 |
Alexandros Ο. Konstantinidis, Dimitra Pardali, Katerina K. Adamama-Moraitou, Maria Gazouli, Chrysostomos I. Dovas, Evangelia Legaki, Georgia D. Brellou, Ioannis Savvas, Albert E. Jergens, Timoleon S. Rallis, Karin Allenspach. Colonic mucosal and serum expression of microRNAs in canine large intestinal inflammatory bowel disease. BMC Veterinary Research 2020; 16(1) doi: 10.1186/s12917-020-02287-6
|
| 9 |
Frank Tacke, Martina E. Spehlmann, Mihael Vucur, Fabian Benz, Mark Luedde, David Vargas Cardenas, Sanchari Roy, Sven Loosen, Hans-Joerg Hippe, Norbert Frey, Christian Trautwein, Alexander Koch, Christoph Roderburg, Tom Luedde. miR-155 Predicts Long-Term Mortality in Critically Ill Patients Younger than 65 Years. Mediators of Inflammation 2019; 2019: 1 doi: 10.1155/2019/6714080
|
| 10 |
Jaslin P. James, Lene Buhl Riis, Mikkel Malham, Estrid Høgdall, Ebbe Langholz, Boye S Nielsen. MicroRNA Biomarkers in IBD—Differential Diagnosis and Prediction of Colitis-Associated Cancer. International Journal of Molecular Sciences 2020; 21(21): 7893 doi: 10.3390/ijms21217893
|
| 11 |
Tommaso Innocenti, Elisabetta Bigagli, Erica Nicola Lynch, Andrea Galli, Gabriele Dragoni. MiRNA-Based Therapies for the Treatment of Inflammatory Bowel Disease: What Are We Still Missing?. Inflammatory Bowel Diseases 2023; 29(2): 308 doi: 10.1093/ibd/izac122
|
| 12 |
Esmerina Tili, Jean-Jacques Michaille, Victoria Piurowski, Brooke Rigot, Carlo M Croce. MicroRNAs in intestinal barrier function, inflammatory bowel disease and related cancers — their effects and therapeutic potentials. Current Opinion in Pharmacology 2017; 37: 142 doi: 10.1016/j.coph.2017.10.010
|
| 13 |
Long-Yuan Zhou, Si-Nan Lin, Florian Rieder, Min-Hu Chen, Sheng-Hong Zhang, Ren Mao. Noncoding RNAs as Promising Diagnostic Biomarkers and Therapeutic Targets in Intestinal Fibrosis of Crohn’s Disease: The Path From Bench to Bedside. Inflammatory Bowel Diseases 2021; 27(7): 971 doi: 10.1093/ibd/izaa321
|
| 14 |
Alexandria J. Shumway, Michael T. Shanahan, Emilie Hollville, Kevin Chen, Caroline Beasley, Jonathan W. Villanueva, Sara Albert, Grace Lian, Moises R. Cure, Matthew Schaner, Lee-Ching Zhu, Surekha Bantumilli, Mohanish Deshmukh, Terrence S. Furey, Shehzad Z. Sheikh, Praveen Sethupathy. Aberrant miR-29 is a predictive feature of severe phenotypes in pediatric Crohn’s disease. JCI Insight 2024; 9(4) doi: 10.1172/jci.insight.168800
|
| 15 |
Petr Jabandziev, Julia Bohosova, Tereza Pinkasova, Lumir Kunovsky, Ondrej Slaby, Ajay Goel. The Emerging Role of Noncoding RNAs in Pediatric Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2020; 26(7): 985 doi: 10.1093/ibd/izaa009
|
| 16 |
Yasmin N. Ramadan, Ayat M. Kamel, Mohammed A. Medhat, Helal F. Hetta. MicroRNA signatures in the pathogenesis and therapy of inflammatory bowel disease. Clinical and Experimental Medicine 2024; 24(1) doi: 10.1007/s10238-024-01476-z
|
| 17 |
Ioanna Aggeletopoulou, Athanasia Mouzaki, Konstantinos Thomopoulos, Christos Triantos. miRNA Molecules—Late Breaking Treatment for Inflammatory Bowel Diseases?. International Journal of Molecular Sciences 2023; 24(3): 2233 doi: 10.3390/ijms24032233
|
| 18 |
Suruchi K Batra, Christopher R Heier, Lina Diaz-Calderon, Christopher B Tully, Alyson A Fiorillo, John van den Anker, Laurie S Conklin. Serum miRNAs Are Pharmacodynamic Biomarkers Associated With Therapeutic Response in Pediatric Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2020; 26(10): 1597 doi: 10.1093/ibd/izaa209
|
| 19 |
Ayelén D. Rosso, Pablo Aguilera, Sofía Quesada, Florencia Mascardi, Sebastian N. Mascuka, María C. Cimolai, Jimena Cerezo, Renata Spiazzi, Carolina Conlon, Claudia Milano, Gregorio M. Iraola, Alberto Penas-Steinhardt, Fiorella S. Belforte. Comprehensive Phenotyping in Inflammatory Bowel Disease: Search for Biomarker Algorithms in the Transkingdom Interactions Context. Microorganisms 2022; 10(11): 2190 doi: 10.3390/microorganisms10112190
|
| 20 |
Horia Minea, Ana-Maria Singeap, Manuela Minea, Simona Juncu, Cristina Muzica, Catalin Victor Sfarti, Irina Girleanu, Stefan Chiriac, Ioana Diandra Miftode, Carol Stanciu, Anca Trifan. The Contribution of Genetic and Epigenetic Factors: An Emerging Concept in the Assessment and Prognosis of Inflammatory Bowel Diseases. International Journal of Molecular Sciences 2024; 25(15): 8420 doi: 10.3390/ijms25158420
|
| 21 |
Reza Yarani, Ali Shojaeian, Oana Palasca, Nadezhda T. Doncheva, Lars Juhl Jensen, Jan Gorodkin, Flemming Pociot. Differentially Expressed miRNAs in Ulcerative Colitis and Crohn’s Disease. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.865777
|
| 22 |
Guanqun Chao, Yingying Wang, Fangxu Ye, Shuo Zhang. Regulation of Colonic Mucosal MicroRNA Expression via Multiple Targets in Visceral Hypersensitivity Rats by Tongxieyaofang. Yonsei Medical Journal 2018; 59(8): 945 doi: 10.3349/ymj.2018.59.8.945
|
| 23 |
Jennifer Bermick, Matthew Schaller. Epigenetic regulation of pediatric and neonatal immune responses. Pediatric Research 2022; 91(2): 297 doi: 10.1038/s41390-021-01630-3
|